HbA1c is the world’s most widely used test for diagnosing type 2 diabetes. New evidence shows that G6PD deficiency and other genetic variants are systematically distorting its results for Black and ...

These plans have been a long time in the making. The intention to produce a strategy ‘to ensure the UK is able to offer a predictive, preventative and personalised health and care service for people ...

In this blog, I will delve into some of the growing acceptance in healthcare to innovative approaches in various countries, and how a database will facilitate analysis and interpretation for all. The ...

Widely regarded as a founder of cell free DNA (cfDNA) technology, Professor Dennis Lo is now pioneering investigation into the emerging science of fragmentomics. If you were at were at our recent ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...

The BMJ reviewed research on health test kits sold in UK supermarkets and uncovered some deeply concerning gaps. Unlike routine diagnostic tests and assays used in clinical practice and prescribed ...

The Wellcome Trust recently announced that they are funding a research programme to investigate synthetic human genomes, and Laura Blackburn, PHG Foundation’s Head of Science, had the opportunity to ...

The UK government has launched a new alliance to sequence the genomes of SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Backed by a £20 million investment, the COVID-19 Genomics ...

The optimism is not unfounded. In specific, well-defined clinical scenarios, polygenic scores are beginning to demonstrate some tangible utility. For cardiovascular disease, MI-GENES, a 10-year follow ...

Sepsis is a critical global healthcare challenge, marked by complex and rapidly evolving symptoms, which can escalate with alarming speed leading to multi-organ failure. This leaves only a narrow ...

A set of consensus statements on the use of biomarkers in cancer research and treatment were released this month. They aim to accelerate the discovery, development, and adoption of biomarkers into the ...

Potential fallout from the recent UK Biobank data exposure – and similar cases – highlights that governance cannot be treated as an administrative add on. It is foundational infrastructure on which ...